2Lau W C,Gurbel P A,Watkins P B,et al.Contribution of hepaticcytochrome P4503A4 metabolic activity to the phenomenon of clo-pidogrel resistance[J].Circulation,2004,109(2):166-71.
3Nguyen T A,Diodati J G,Pharand C.Resistance to clopidogrel:a review of the evidence[J].J Am coll Cardiol,2005,45(8):1157-64.
4Geisler T,Langer H,Wydymus M,et a1.Low response to clopi-dogrel is associated with cardiovaseular outcome after coronary stentimplantation[J].Eur Heart J,2006,27(20):2420-5.
5Mason P J,Jacobs A K,Freedman J E.Aspirin resistance andatherothrombotic disease[J].J Am Coll Cardiol,2005,46(6):986-93.
6Tavassoli N,Voisin S,Carrie D,et al.High maintenance dosageof clopidogrel is associated with a reduced risk of stent thrombosisin clopidogrel-resistant patients[J].Am J Cardiovasc Drugs,2010,10(1):29-35.
7Vivekananthan D P,Bhatt D L,Chew D P,et al.Effect of clopi-dogrel pretreatment on periprocedural rise in C-reactive protein af-ter percutaneous coronary intervention[J].Am J Cardiol,2004,94(3):358-60.
8Cha J K,Jeong M H,Lee K M,et al.Changes in platelet P-se-lectin and in plasma C-reactive protein in acute atherosclerotic is-chemic stroke treated with a loading dose of clopidogrel[J].JThromb Thrombolysis,2002,14(2):145-50.
9Patrono C, Garcia Rodriguez LA, Landolfi R, et al. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med, 2005,353 : 2373-2383.
10Bartolucci AA, Howard G. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin. Am J Cardiol,2006 ,98 :746-750.
2Bertrand ME,Legrand V,Boland J,et al.Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting:the full anticoagulation versus aspirin and ticlopidine(FANTASTIC)study[J].Circulation,1998,98:1597-1603.
3Schmig A,Neumann FJ,Kastrati A,et al.A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents[J].N Engl J Med,1996,334:1084-1089.
4Leon MB,Baim DS,Popma JJ,et al.Stent anticoagulation restenosis study investigators.A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting[J].New Engl J Med,1998,339:1665-1671.
5Pandit A,Giri S,Hakim FA,et al.Shorter(≤6 months)versus longer(≥12 months)duration dual antiplatelet therapy after drug eluting stents:a meta-analysis of randomized clinical trials[J].Catheter Cardiovasc Interv,2014.[Epub ahead of print].
6Muller I,Besta F,Schulz C,et al.Prevalence of clop-I dogrel non-responders among patientswith stable anginapectoris scheduled for elective coronary stent placement[J].Thrombo Haemost,2003,89(5):783-787.
